Search results
-
Dr Catherine Lindon
... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...
-
Dr Athena Matakidou
... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...
-
Dr Mariann Bienz
... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...
-
Dr Dario Bressan
... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...
-
Dr Frank McCaughan
My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...
-
Professor Gillian Murphy
... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...
-
Dr James Nathan
Cellular mechanisms of oxygen and metabolite sensing: ...
-
Dr James Rudd
... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...
-
Ms Paola Marco
... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...
-
Dr Marisa Segal
... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Mr Asif Jah
Mr Asif Jah ...
-
Miss Nicola Fearnhead
Miss Nicola Fearnhead has been a Consultant Colorectal Surgeon at Addenbrooke's Hospital, Cambridge since 2006. She is a graduate of Pembroke College, Cambridge and Merton College, Oxford where she was a Rhodes Scholar. Surgical training was...
-
Professor Grant Stewart
Professor Stewart is an academic surgeon at the University of Cambridge, with a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising management of patients with...
-
Dr Giovanna Zinzalla
HOW TRANSCRIPTIONAL REGULATORS CONTROL GENE EXPRESSION PROGRAMS AND CELL FATE IN NORMAL AND MALIGNANT CELLS How the transcriptional machinery orchestrates gene expression programs during development, renewal and in response to environmental...
-
Professor Julie Ahringer
We investigate the functions chromatin regulatory complexes implicated in human disease using the C. elegans model system. These include the histone deacetylase complex NuRD, the Retinoblastoma complex DRM, and a TIP60 histone acetyltransferase complex....
-
Dr Laura Blackburn
PHG Foundation are a health policy unit with a focus on how genomics and emerging technologies can provide more effective, personalised healthcare. We help governments, policy makers and health professionals tackle barriers to progress and implement...
-
Dr Maya Ghoussaini
Our main focus is the identification of genetic variants influencing susceptibility to breast cancer. We have recently identified seventy seven new breast cancer susceptibility loci using a genome-wide approach. In order to find the disease-causative...
-
Professor Paul J Lehner
We study MHC I molecules and other critical cell surface receptors. We showed that the cancer-causing herpesviruses (KSHV) pirated ubiquitin E3 ligases from their vertebrate hosts. These ligases ubiquitinate and downregulate critical cell surface...
-
Miss Amy Hudson
-
Ms Adeline Nicholas
-
Dr Anastasia Tsyben
-
Dr Andrew Reynolds
-
Dr Brian Hendrich
-
Dr Chiwen Chang
1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.
-
Mr Callum Malcolm
-
Dr Simon Cook
In terms of basic science we are interested in how protein kinase and lipid signalling pathways control cell fate decisions such as proliferation versus differentiation and survival versus death. However, these pathways are frequently de-regulated in...
-
Mr Douglas van Niekerk
-
Dr Joanna Baxter
-
Dr Adrian Ionescu
I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, University of Cambridge, in the Thin Film Magnetism (TFM) group with Prof. Crispin Barnes on an ERC International Training Network project,...
-
Dr Aisling Redmond
Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...
-
Dr Fazlur Rahman Talukdar
I am spearheading a translational research initiative focused on developing circulating tumour DNA (ctDNA) based biomarkers derived from minimally invasive biospecimens, with the primary objective of early cancer detection and monitoring. I am a...
-
Dr Hayley Woffendin
After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...
-
Dr Helen Hatcher
Dr Hatcher is the Clinical and Regional lead for young people with cancer specialising in sarcomas and other rare cancers. She qualified in medicine at the University of Cambridge and has trained at the Royal Marsden Hospital in London. Her PhD and post...
-
Dr Hanna Najgebauer
Open Targets Postdoctoral Fellow responsible for the development of new algorithms and computational tools for scoring cancer in vitro models based on their clinical relevance and covered genomic heterogeneity observed in primary disease.
-
Mr Justin Davies
Justin Davies Clinical Director of Digestive Diseases and Consultant Colorectal Surgeon at Addenbrooke's Hospital, and an Associate Lecturer at the University of Cambridge. His thesis was written on molecular stool screening for colorectal cancer, and...
-
Dr Kate Fife
Dr Kate Fife is a consultant clinical oncologist at Addenbrooke's Hospital, Cambridge where she was appointed in 2001. Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic which is one of the...
-
Dr Myriam Ouberai
I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...
-
Dr Roy Rabbie
We use DNA sequencing of patients and their tumours to study genomic evolution in melanoma.
-
Dr Heather Zecchini
Light Microscopy Imaging
-
Dr John Lizhe Zhuang
... may manifest even before cancer fully develops, shedding light on the optimal timing for early cancer detection. Secondly, our research ...
-
Dr Ragnhildur Thora Karadottir
The CNS white matter links billions of neurons in the grey matter. Its function depends on oligodendrocytes enwrapping neuronal axons with myelin to synchronize and increase information flow between neurons: essential for our cognitive abilities, our...
-
Dr Sara Lightowlers
-
Dr Sam Stranks
... low-cost, transformative electronics applications including light-harvesting (e.g. solar cells) and light-emission (eg LED) devices. We have developed a range of in-situ and ...
-
Dr Lucy Yates
I use cutting-edge genomic technologies to explore the evolutionary basis of clinical cancer progression. ...